One of the most prominent priorities during the COVID-19 pandemic is sustaining the gains toward HIV epidemic control and ensuring continuity of treatment and support for viral suppression among people living with HIV (PLHIV), including members of key populations (KPs).
This webinar, the first in a series on the topic of COVID-19 and HIV, is organized by the International AIDS Society (IAS) and will be held on Friday, April 3, from 10 - 11:30 am SAST. The webinar is openly recommended to HIV professionals, government representatives working in the field of HIV, public health specialists, programme managers, service providers, civil society representatives and members of organizations supporting key and vulnerable populations.
You are invited to an upcoming webinar, "Leveraging differentiated ART delivery models for TB preventive therapy," on Tuesday, 24 March, 15:00 CET. Hosted by the Differentiated Service Delivery (DSD) initiative of the International AIDS Society (IAS) the webinar will explore how an integrated DSD approach can support the scale up of and access to tuberculosis preventive therapy (TPT) for people living with HIV.
Boost is a mobile phone app and website designed and developed in collaboration with community health workers and peer educators in southern Africa. Boost provides easy, up-to-date, visual and interactive materials on HIV and sexual health.
Sofia Bandomia and her team in Portuguese-speaking Mozambique had long found it challenging to enroll men living with HIV in care and treatment. What she found 5,000 miles, 11 countries and a language away in Cote d’Ivoire changed that.
The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world.
A strategy of early ART had no effect on condomless sex with HIV-serodifferent partners among MSM, but resulted in modestly higher prevalence among heterosexuals. However, among MSM and heterosexuals, early ART resulted in a substantial reduction in HIV-transmission-risk sex, to a very low absolute level.